This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Thymus
CD2_BENIGN_THYMUS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D15
- Name in latin
- Neoplasma benignum thymi
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Thymus
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Thymus
- Benign neoplasm of other and unspecified intrathoracic organs
- Benign neoplasm of other and unspecified intrathoracic organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 76 | 39 | 37 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 61.70 | 58.78 | 64.78 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 62
- Matched controls
- 621
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D15.0
ICD-10 Finland
Benign neoplasm: Thymus
+∞
83.7
60
*
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
+∞
27.1
24
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
+∞
25.8
23
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
17.9
17.1
28
27
GEC23
NOMESCO Finland
Transsternal thymectomy
+∞
15.2
14
*
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
+∞
14.1
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.7
12.2
47
179
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
14.9
9.8
16
14
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
9.6
9
*
8582/3-C37.9
ICD-O-3
Thymoma, type AB of thymus
+∞
9.6
9
*
C37
ICD-10 Finland
Malignant neoplasm of thymus
+∞
9.6
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.6
9
*
N07AA02
ATC
pyridostigmine; systemic
103.6
8.6
9
*
ZXC96
NOMESCO Finland
Robot assisted procedure
103.6
8.6
9
*
108
Kela drug reimbursment
Myasthenia gravis
+∞
8.5
8
*
8580/3-C37.9
ICD-O-3
Thymoma, NOS, of thymus
+∞
8.5
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.9
8.1
25
63
D15.2
ICD-10 Finland
Benign neoplasm: Mediastinum
+∞
7.4
7
*
R4110
NOMESCO Finland
Physiotherapy
5.0
7.4
28
88
WX408
NOMESCO Finland
General anesthesy, balanced
4.8
7.4
29
95
GD1AD
NOMESCO Finland
Thorax CT examination
19.5
7.0
10
6
WZC30
NOMESCO Finland
Teaching
6.9
6.8
17
32
B01AB05
ATC
enoxaparin; parenteral
4.5
6.8
28
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
42
130
5.99
13.86
2.4
2.0
—
—
—
0
0
62
286
7.34
12.50
9.5
5.7
1.2
1.2
mmol/l
0.34
57
251
57
253
6.01
11.76
3.7
3.5
—
—
—
0
0
20
36
7.18
11.39
15.3
9.0
0.6
0.8
%
0.75
20
36
19
37
6.51
9.96
15.9
8.8
1.2
1.6
%
0.62
19
37
61
335
5.16
8.45
14.1
6.3
4.1
4.2
e9/l
0.14
52
284
45
202
4.01
8.21
4.1
3.1
—
—
—
0
0
23
72
4.15
6.83
15.3
6.3
104.2
103.8
mmol/l
0.12
23
72
35
151
3.44
6.44
3.7
2.9
0.2
0.6
e6/l
1.63
27
110
10
17
6.62
5.79
3.3
3.2
—
—
—
0
0
24
88
3.52
5.59
3.4
2.7
5.9
2.8
e6/l
0.35
13
45
39
195
3.05
5.41
2.5
2.6
24.1
30.0
u/l
2.20
39
185
25
101
3.20
4.94
3.4
2.5
0.6
1.3
e6/l
1.04
14
58
13
35
4.27
4.59
7.8
7.2
26.0
25.3
mmol/l
0.36
13
35
7
6
12.66
4.36
1.3
1.0
—
—
—
0
0
7
7
10.85
4.10
1.3
1.3
—
—
—
0
0
10
27
4.11
3.48
5.0
4.3
2.0
1.4
mmol/l
—
10
21
12
38
3.56
3.38
1.6
1.4
—
—
—
0
0
35
201
2.37
3.31
2.5
2.1
161.5
170.7
u/l
0.08
35
188
19
84
2.68
3.08
2.3
2.7
12.3
14.4
umol/l
0.57
19
78
5
5
10.57
3.02
1.0
1.8
4.7
2.9
u/ml
—
5
5
38
234
2.25
2.98
1.7
1.8
91.1
92.9
pmol/l
0.12
29
112
6
9
7.12
2.92
1.2
1.0
—
—
—
0
0
19
87
2.58
2.87
1.9
1.6
—
—
—
0
0
16
68
2.71
2.78
1.6
1.5
—
—
—
0
0
6
10
6.40
2.75
1.0
1.1
—
—
—
0
0
7
17
4.42
2.42
2.4
1.6
—
—
—
0
0
24
132
2.20
2.40
3.0
3.5
25.3
197.5
ng/l
2.00
19
109
43
303
1.97
2.16
4.8
4.8
0.0
0.0
estimate
—
8
42
15
70
2.42
2.15
1.9
1.5
—
—
—
0
0
43
308
1.91
2.01
3.5
3.6
0.0
0.0
estimate
—
7
40
7
22
3.40
1.93
3.6
1.1
0.0
0.0
g/l
—
7
22
7
22
3.40
1.93
3.6
1.1
0.0
0.0
g/l
—
7
22
10
40
2.73
1.92
1.5
1.3
—
—
—
0
0
5
12
4.38
1.85
2.6
1.9
—
—
—
0
0
5
12
4.38
1.85
1.6
1.2
—
—
—
0
0
41
297
1.83
1.78
3.5
3.6
0.0
0.0
estimate
—
7
45
53
416
1.91
1.77
3.6
3.1
76.4
51.2
u/l
0.38
53
388
7
25
2.98
1.69
3.6
1.2
0.0
0.0
g/l
—
7
25
6
20
3.16
1.61
6.2
4.5
24.2
24.6
mmol/l
—
6
20
8
33
2.59
1.59
3.3
1.2
—
—
—
0
0
22
136
1.87
1.55
1.6
1.4
18.1
20.9
nmol/l
0.55
22
114
20
124
1.83
1.39
3.5
2.2
2.5
2.4
mmol/l
0.45
15
109
5
17
3.07
1.38
2.0
1.5
—
—
—
0
0
7
32
2.30
1.11
1.6
1.5
—
—
—
0
0
7
33
2.23
1.09
7.6
2.5
1.2
1.3
%
—
7
33
13
77
1.83
1.03
1.2
1.4
—
—
—
0
0
29
215
1.56
1.02
2.5
2.2
61.5
57.8
u/l
0.27
29
198
66
598
1.79
0.90
21.8
10.9
81.1
80.1
ml/min/173m2
0.14
60
474
0
25
0.00
0.80
0.0
1.4
—
—
—
0
0
9
54
1.75
0.78
8.9
4.7
64.0
98.3
ng/l
—
9
48
32
255
1.44
0.77
5.2
3.8
40.3
51.9
ng/l
0.25
26
184
15
110
1.45
0.54
1.1
1.3
1.2
11.7
u/ml
—
5
54
8
57
1.45
0.44
2.9
1.7
—
—
—
0
0
15
115
1.38
0.43
1.9
1.9
460.3
485.3
pmol/l
0.17
15
103
0
17
0.00
0.41
0.0
1.3
—
2.1
—
0
10
15
184
0.77
0.33
3.4
3.4
16.7
24.7
%
—
9
93
7
53
1.35
0.32
2.6
1.5
—
—
—
0
0
40
366
1.20
0.27
3.1
2.7
—
—
—
0
0
6
84
0.69
0.25
10.7
7.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
8
69
1.18
0.17
1.3
3.0
31.8
7.3
ug/l
—
8
58
50
481
1.12
0.12
3.9
3.7
15.0
15.0
pmol/l
0.04
43
434
13
115
1.16
0.11
2.1
1.7
978.3
1240.4
nmol/l
0.58
13
91
18
166
1.11
0.08
4.9
3.9
0.0
0.0
estimate
—
7
44
15
140
1.09
0.05
1.1
1.3
0.8
1.0
u/ml
—
5
41
18
188
0.94
0.02
1.3
1.7
1.4
1.4
mmol/l
0.03
18
160
24
233
1.04
0.01
4.7
3.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
8
82
0.97
0.00
1.6
1.5
—
—
—
0
0
5
56
0.89
0.00
2.6
3.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
23
230
1.00
0.00
5.7
3.6
3.9
1.9
ug/l
0.84
23
210
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
20.1
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_THYMUS_EXALLC – Benign neoplasm: Thymus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).